Alterations of Cardiac ERK1/2 Expression and Activity Due to Volume Overload Were Attenuated by the Blockade of RAS

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cardiovascular Pharmacology and Therapeutics

• Publication date

  2010-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1074248409356430PMID 20100902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.

  2008cited by this paper
• Alterations in both death and survival signals for apoptosis in heart failure due to volume overload.

  2007cited by this paper
• MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.

  2006cited by this paper
• Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy.

  2005cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibitor Versus Angiotensin II Receptor Blocker

  2005cited by this paper
• Modification of sarcolemmal Na+-K+-ATPase and Na+/Ca2+ exchanger expression in heart failure by blockade of renin-angiotensin system.

  2005cited by this paper
• Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.

  2004cited by this paper
• Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation

  2004cited by this paper
• Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat.

  2003cited by this paper
• A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy

  2003cited by this paper
• Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

  2002cited by this paper
• Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats

  2002cited by this paper
• Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats.

  2001cited by this paper
• Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.

  2000cited by this paper
• The renin-angiotensin system and experimental heart failure.

  1999cited by this paper
• Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.

  1999cited by this paper
• Regulation of growth in the adult cardiomyocytes

  1999cited by this paper
• Activation of mitogen-activated protein kinases in cardiovascular hypertrophy and remodeling.

  1999cited by this paper
• Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.

  1998cited by this paper
• Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats.

  1998cited by this paper
• Remodeling of Cardiac Membranes During the Development of Congestive Heart Failure

  1998cited by this paper
• The role of protein kinases in adaptational growth of the heart.

  1996cited by this paper
• Angiotensin II mediates mechanical stress-induced cardiac hypertrophy.

  1996cited by this paper
• The role of the cardiac renin-angiotensin system in load-induced cardiac hypertrophy.

  1996cited by this paper
• Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes*

  1996cited by this paper
• Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy.

  1996cited by this paper
• Nitric oxide release from kidneys of hypertensive rats treated with imidapril.

  1996cited by this paper
• ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation.

  1995cited by this paper
• Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.

  1995cited by this paper
• The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat.

  1995cited by this paper
• Evaluation of the needle technique for producing an arteriovenous fistula.

  1994cited by this paper
• Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.

  1994cited by this paper
• Ventricular dilatation and remodeling after myocardial infarction.

  1994cited by this paper
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain.

  1993cited by this paper
• Ventricular remodeling after myocardial infarction.

  1993cited by this paper
• Hemodynamic changes in rats after opening an arteriovenous fistula.

  1992cited by this paper
• Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.

  1991cited by this paper
• Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

  1990cited by this paper
• Angiotensin II-forming pathways in normal and failing human hearts.

  1990cited by this paper
• Neuroendocrine activation after acute myocardial infarction.

  1990cited by this paper
• Simple, rapid, and effective method of producing aortocaval shunts in the rat.

  1990cited by this paper
• Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications

  1990cited by this paper
• Neuroendocrine activation after acute myocardial infarction.

  1988cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Contributions of mechanical loading and hormonal changes to eccentric hypertrophy during volume overload: A Bayesian analysis using logic-based network models

  2025influential citation
• Contributions of mechanical loading and hormonal changes to eccentric hypertrophy during volume overload: a Bayesian analysis using logic-based network models

  2024cites this paper
• Role of angiotensin II in the development of subcellular remodeling in heart failure

  2021cites this paper
• Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease

  2021cites this paper
• Salt, Angiotensin II, Superoxide, and Endothelial Function.

  2015cites this paper
• Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.

  2014cites this paper
• Modulation of C16:0‐ceramide in hypertrophied immature hearts by losartan

  2013cites this paper
• Protein Kinases as Drug Development Targets for Heart Disease Therapy

  2010cites this paper
• Contributions of mechanical loading and hormonal changes to eccentric 1 hypertrophy during volume overload: a Bayesian analysis using logic-based 2 network models. 3

  year unknowncites this paper